ArticleTherapeutic advances in hematology2026

A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis.

Masashi Sawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.